DESDE 2012
El Lush Prize surgió del la voluntad de los fundadores de Lush para acabar con la experimentación animal. Creían que las alternativas al testado sin crueldad tardaban demasiado en generalizarse. Así que tuvieron una idea: crear un fondo de 250.000 libras anuales que financiaría distintas iniciativas para acabar con esta práctica.
El Lush Prize se presentó en 2012 en colaboración con la organización Ethical Consumer, convirtiéndose en el premio con un mayor fondo destinado al sector de la experimentación sin animales. En 2018 empezó a conceder 330.000 libras esterlinas, y ahora es un premio bienal.
Durante este tiempo se ha convertido en un premio global, y ha apoyado a activistas y a proyectos científicos en países de todo el mundo, como China, Kenia, Irán, Ucrania e India, Nueva Zelanda, Brasil, Estados Unidos y toda Europa. El objetivo de Lush es apoyar el trabajo que permita avanzar más en este campo, garantizando que la investigación sin animales continúe teniendo el mayor impacto posible. Para ello, proporcionamos recursos que repartimos a proyectos de estas cinco categorías:
- La categoría de Ciencia y la de Joven Investigador, concebidas para impulsar la investigación en alternativas de experimentación sin animales.
- La categoría de Formación está destinada a financiar proyectos de formación centrados en alternativas libres de crueldad para profesionales de la ciencia o responsables de las regulaciones normativas.
- Las categorías de Conciencia Pública y Logros Políticos tienen como objetivo premiar proyectos que garanticen la presión para asegurar que la normativa sea adecuada y se actualice para reflejar los avances realizados en la toxicología del siglo XXI.
Además de estas categorías, si se produce un avance importante que nos acerque a eliminar definitvamente las pruebas con animales, se puede conceder un Black Box Prize. Este premio, que se concedió por primera vez en 2015, puede alcanzar el importe íntegro del Lush Prize.
Descubre más información sobre los ganadores del Lush Prize en su web y en Twitter.
Meet some past winners of The Lush Prize
Lobbying
Public Awareness
Science
Training
Young Researcher
Andrew Tyler
New: Political Achievement
Lobbying
Public Awareness
Science
Training
Young Researcher
Andrew Tyler Award
Lobbying
Public Awareness
Science
Training
Young Researchers
Andrew Tyler Award
2012
We had 13 outstanding winners of the 2012 Lush Prize Awards.
Each prize award page has full details, video interviews with some of the winners and a reminder of those who were also short-listed.
Lobbying Prize – 3 award winners
Public Awareness Prize – 3 award winners
Science Prize – 1 award winner
Training Prize – 2 award winners
Young Researcher Prize – 4 award winners
Watch for a full update on what our winners did next
2013
In its second year, the Prize had a more than 40% increase in nominations from science projects, and we had 12 outstanding winners of the 2013 Lush Prize Awards sharing prize money of £250,000, plus one Special Award.
They include researchers in university departments from Cardiff to Innsbruck and campaigners from the USA and Sweden. See full details of the winners and also those who were short-listed:
Lobbying Prize – 2 award winners
Public Awareness Prize – 2 award winners
Science Prize – 2 award winners
Training Prize – 2 award winners
Young Researcher Prize – 4 award winners
Special Award – 1 recipient
2014
2015
In addition to £200,000 being shared by the winners of the lobbying, training, public awareness, science and young researcher awards, this year the judges decided to present our first ever Black Box awards, totalling £250,000, to winners involved in mapping the first ever ‘human toxicity pathway’.
Congratulations to all our award winners, and to the other short-listed nominees.
BLACK BOX PRIZE
Key breakthroughs in human toxicity pathways research
The Lush Prize judges believe that mapping the ‘human toxicity pathway’ represents a breakthrough moment marking the first step into a future where a superior molecular science replaces the old, imprecise, technology of testing on animals in laboratories. The award recognises the work conducted on the ‘skin sensitisation pathway’ and has been divided between five winners.
£150,000: The OECD’s Adverse Outcome Pathway programme, France
The programme, directed by Bob Diderich, oversees a range of activities including:
- identifying new non-animal test methods that are candidates to become international ‘Test Guidelines’;
- managing an ‘AOP Knowledge Base’ which is a web-based platform to bring together all knowledge on how chemicals can induce adverse effects.
The OECD is a Paris-based organisation which “provides a forum in which governments can work together to share experiences and seek solutions to common problems.”
£25,000: David Basketter, UK
David is a UK-based researcher who has published over 300 papers on skin sensitisation, bridging the gap between industry and academic research.
He has focussed particularly on trying to predict whether chemicals will cause allergy from their molecular structure and has also chaired important European groups focussed on non-animal tests.
£25,000: Frank Gerberick, USA
Dr Gerberick’s primary research focus has been in the field of skin allergy with over 170 publications. He has also co-authored a book ‘Toxicology of Contact Dermatitis’.
His laboratory at Procter & Gamble in the USA has developed one of the first widely-used non-animal test (the DPRA) to predict toxicity at the first stage in the skin sensitisation pathway.
£25,000: Andreas Natsch / Roger Emter, Switzerland
Andreas Natsch and his colleague Roger Emter have led the development of the second non-animal test to reliably predict toxicity within the skin sensitisation pathway.
Their ‘KeratinoSens’ method, developed in the Givaudan laboratories in Switzerland, uses a human cell line in a test tube and looks for a particular type of gene signalling.
£25,000: Terry Schultz, USA
Terry is emeritus professor at the University of Tennessee where he directed the Biological Activity Testing and Modelling Laboratory.
His focus has been the non-animal testing of chemicals for toxicity and building computer databases of results to help predict outcomes.
He played a key role in mapping the whole pathway in the two 2012 OECD research papers ‘The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins.’
2016
2017
12:11